Search for: "Cooke v. Delaware"
Results 61 - 80
of 120
Sorted by Relevance
|
Sort by Date
28 Jan 2019, 8:18 pm
(Schnatter v. [read post]
9 Nov 2023, 10:00 am
The court in Pannu v. [read post]
15 Nov 2019, 6:17 am
Cook & Co., on Saturday, November 9, 2019 Tags: CD&A, Derivatives, Disclosure, Hedging, Management, Proxy advisors, Proxy disclosure, SEC, SEC rulemaking, Securities regulation The Stewardship Implications of Passive Investing: Mobilizing Large Asset Managers as Stewards of Capital Markets Posted by Jackie Cook and Jasmin Sethi, Morningstar, Inc., on Saturday, November 9, 2019 Tags: Asset… [read post]
25 Oct 2007, 5:15 am
With Delaware law making a sham of fiduciary obligations, civil remedies are in decline. [read post]
26 Oct 2010, 8:43 pm
The Ninth Circuit’s opinion in Ricky Lee Earp v. [read post]
23 Mar 2014, 6:57 pm
Northern Grain Marketing, LLC v. [read post]
3 Nov 2014, 10:19 am
The court cited Powerex Corp. v. [read post]
10 Sep 2014, 7:33 am
Fortunee Massuda v. [read post]
11 Sep 2012, 4:25 am
Consider their #1 state, Delaware: that’s where, in Dambro v. [read post]
25 Oct 2022, 10:46 am
(citing Bowen v. [read post]
27 Dec 2017, 7:00 am
***Finally, for this year, I thought the Sixth Circuit's opinion in Hall v. [read post]
28 Jul 2015, 1:34 pm
Inc. v. [read post]
3 May 2017, 3:00 am
Chung v. [read post]
14 Nov 2014, 7:25 am
The Florida case is Eghnayem v. [read post]
12 Jul 2010, 5:46 am
Edwards Lifesciences AG v Cook Biotech Incorporated (IPKat) England’s new shirt sponsors? [read post]
2 Oct 2023, 6:33 am
Cook that The Western Union Co. [read post]
21 May 2015, 7:49 pm
Denton v. [read post]
17 Nov 2011, 8:00 am
William V. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram)… [read post]
12 Nov 2010, 12:53 am
Sybase, Inc. et al (271 Patent Blog) (Docket Report) District Court Delaware : Judgment of nonobviousness does not collaterally estop later assertion of anticipation defense involving the same patents and prior art: Power Integrations Inc. v. [read post]
